Smedley D, Demiroglu A, Abdul-Rauf M, Heath C, Cooper C, Shipley J, Cross N C
Molecular Carcinogenesis Section, Institute of Cancer Research, Haddow Laboratories, Belmont, Surrey, UK.
Neoplasia. 1999 Oct;1(4):349-55. doi: 10.1038/sj.neo.7900035.
The ZNF198- FGFR1 fusion gene arises as a result of the t(8;13)(p11;q12) in the 8p11 myeloproliferative syndrome. To determine the transforming properties of this chimeric protein we transfected ZNF198-FGFR1 into the interleukin (IL)-3 dependent cell line Ba/F3. Growth factor independent subclones were obtained in which ZNF198-FGFR1, STAT1, and STAT5 were constitutively tyrosine phosphorylated, as determined by immunoprecipitation and Western blot analysis. To test the hypothesis that constitutive activation of ZNF198-FGFR1 tyrosine kinase activity is a result of self-association of the fusion protein, we in vitro transcribed and translated ZNF198-FGFR1 and a derivative construct, ZNF198- FGFR1deltaC-myc, in which the C-terminal FGFR1 epitope was replaced by a c-myc tag. As expected, an anti-FGFR1 antibody immunoprecipitated ZNF198-FGFR1 but not ZNF198-FGFRdeltaC-myc. However when both products were translated together, both were coimmunoprecipitated by anti-FGFR1 antisera. Similar results were obtained by using an anti-myc antibody and demonstrated a physical interaction between the two proteins. Analysis of COS-7 cells transfected with ZNF198-FGFR1 demonstrated that the fusion gene, in contrast to normal FGFR1, is located in the cytoplasm. We conclude that ZNF198-FGFR1 is a cytoplasmic protein that self-associates and has constitutive transformation activity. These data suggest that ZNF198-FGFR1 plays a primary role in the pathogenesis of the t(8;13) myeloproliferative syndrome and is the first report to implicate STAT proteins in FGFR1-mediated signaling.
ZNF198 - FGFR1融合基因源于8p11骨髓增殖综合征中的t(8;13)(p11;q12)。为了确定这种嵌合蛋白的转化特性,我们将ZNF198 - FGFR1转染到依赖白细胞介素(IL)-3的细胞系Ba/F3中。通过免疫沉淀和蛋白质免疫印迹分析确定,获得了生长因子非依赖性亚克隆,其中ZNF198 - FGFR1、信号转导和转录激活因子1(STAT1)和信号转导和转录激活因子5(STAT5)持续酪氨酸磷酸化。为了验证ZNF198 - FGFR1酪氨酸激酶活性的持续激活是融合蛋白自缔合的结果这一假设,我们在体外转录并翻译了ZNF198 - FGFR1和一种衍生构建体ZNF198 - FGFR1deltaC - myc,其中FGFR1的C末端表位被c - myc标签取代。正如预期的那样,抗FGFR1抗体免疫沉淀了ZNF198 - FGFR1,但没有沉淀ZNF198 - FGFRdeltaC - myc。然而,当两种产物一起翻译时,两者都被抗FGFR1抗血清共免疫沉淀。使用抗myc抗体也获得了类似的结果,证明了这两种蛋白之间存在物理相互作用。对用ZNF198 - FGFR1转染的COS - 7细胞的分析表明,与正常FGFR1不同,融合基因位于细胞质中。我们得出结论,ZNF198 - FGFR1是一种自缔合且具有持续转化活性的细胞质蛋白。这些数据表明ZNF198 - FGFR1在t(8;13)骨髓增殖综合征的发病机制中起主要作用,并且是首次报道STAT蛋白参与FGFR1介导的信号传导。